Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Search

Reset Filter
You have a filtered search result

39 search results for ‘*’


Tools & Techniques Imaging

Catching Viral RNA Translation in the Act

Bicistronic biosensor illuminates when a virus hijacks its host


Tools & Techniques Diagnostics & prognostics

Catching Stroke Early with Blood-Based Testing

| Olivia Gaskill

Blood biomarkers specific to brain damage may help identify early signs of stroke

Research Field Genetics

New Meta-DNA Structures for DNA Origami

A new type of meta-DNA structure promises transformation in the fields of optoelectronics and synthetic biology

Disease Area Cell & molecular biology

Protein Expression In Neurogenesis: Right Place, Right Time?

| Olivia Gaskill

Phf21b, a protein associated with intellectual disability and depression, plays a crucial role in neurogenesis.

Research Field Genetics

Gut Feeling

| Phoebe Harkin

Twin study investigates how gut organisms influence the immune system

Research Field Drug discovery

Small, But Mighty

| Brent R Stockwell

Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy

Tools & Techniques Diagnostics & prognostics

All the RAGE

| Luke Turner

A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer

Research Field Biomedical engineering

Corneal Construction

| Jonathan James

Researchers fine-tune 3D printing technology to create better biomimetic corneas – and predict a “breakthrough” in global transplantation practice.

Tools & Techniques Omics

A Microbial Map to Cancer

| Michael Schubert

A new study uses machine learning to perform meta-analysis of eight metagenomic studies linking gut microbial signatures with colorectal cancer.

Disease Area Metabolism & Diabetes

Tackling the Fatty-Liver Timebomb

| Jonathan James

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register